- Raw materials
- Alkalinizing agents
- Sodium tripolyphosphate
Sodium tripolyphosphate API Manufacturers & Suppliers
0 verified results
Commercial-scale Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Sodium tripolyphosphate | CAS No: 7758-29-4 | GMP-certified suppliers
A medication that serves as a veterinary-approved inorganic compound primarily used for industrial applications, with benefits in metal ion sequestration and formulation excipient roles.
Therapeutic categories
Product Snapshot
- Sodium tripolyphosphate is an inorganic compound used primarily as a pharmaceutical excipient rather than a direct formulation type
- Its main uses include applications in veterinary pharmaceutical formulations as a stabilizer or sequestrant
- It is approved for use in veterinary markets but does not have human pharmaceutical approval status such as FDA or EMA
Clinical Overview
Although sodium tripolyphosphate is not indicated for direct therapeutic use in humans, it holds approval for veterinary applications. It is predominantly utilized industrially, most notably as a detergent additive due to its ability to sequester metal ions and improve cleaning performance. Its role in pharmaceutical formulations or as an active pharmaceutical ingredient (API) is not routine.
Pharmacodynamic and mechanism of action details are not specified for sodium tripolyphosphate, reflecting its classification as an excipient or industrial compound rather than a pharmacologically active agent. Similarly, formal absorption, distribution, metabolism, and excretion (ADME) parameters are not defined. Its inorganic nature and ionic composition suggest minimal systemic bioavailability and metabolism when used in approved contexts.
Safety and toxicity considerations for sodium tripolyphosphate primarily relate to its chemical properties and exposure route. It can act as an irritant upon contact with skin or mucous membranes and may impact renal function if ingested in significant amounts due to phosphate load. Appropriate handling and use follow standard industrial hygiene practices. Regulatory approvals reflect safety assessments tied to specific applications, including veterinary uses.
Sodium tripolyphosphate is incorporated into several commercial products, especially detergents and cleaning agents, rather than as a standalone pharmaceutical API. For API procurement, material purity, consistent particle size, and compliance with relevant pharmacopeial standards or veterinary specifications should be confirmed. Trace metal content and absence of contaminants must be verified to ensure quality and safety for authorized applications.
Identification & chemistry
| Generic name | Sodium tripolyphosphate |
|---|---|
| Molecule type | Small molecule |
| CAS | 7758-29-4 |
| UNII | 9SW4PFD2FZ |
| DrugBank ID | DB11493 |
Formulation & handling
- Sodium tripolyphosphate is a small molecule inorganic compound primarily suitable for oral formulations rather than injectables.
- Due to its inorganic phosphate nature, it may require consideration for stability in formulations sensitive to phosphate interactions.
- Its solid state and hydrophilic properties suggest ease of handling and potential compatibility with aqueous systems.
Regulatory status
Sodium tripolyphosphate is a type of Alkalinizing agents
Alkalinizing agents, a pharmaceutical API category, refers to a group of substances used to increase the pH (alkalinity) of a solution or body fluid. These agents play a crucial role in various medical applications, such as the treatment of acidosis, kidney disorders, and certain drug overdoses.
One commonly used alkalinizing agent is sodium bicarbonate, which is highly effective in raising the pH of blood and urine. It works by neutralizing excess acid and restoring the acid-base balance in the body. Sodium bicarbonate is often administered intravenously in emergency situations to rapidly correct severe acidosis.
Another alkalinizing agent, acetazolamide, is frequently employed in the treatment of glaucoma and certain types of epilepsy. By inhibiting carbonic anhydrase, acetazolamide reduces the production of bicarbonate ions, leading to a systemic decrease in pH. This mechanism is particularly useful in lowering the intraocular pressure associated with glaucoma.
Alkalinizing agents are also utilized in the management of certain drug toxicities. For instance, methotrexate, a chemotherapy medication, can cause severe toxicity if its elimination is hindered. Alkalinizing the urine with agents like sodium bicarbonate enhances methotrexate solubility, preventing the formation of toxic crystals in the kidneys.
In conclusion, alkalinizing agents are indispensable pharmaceutical APIs that help correct acid-base imbalances, treat specific medical conditions, and mitigate drug toxicities. Their diverse applications make them valuable tools in modern medicine.
